{"id":{"repo_id":"rowan","oai_identifier":"oai:rdw.rowan.edu:etd-3549"},"canonical_url":"https://search.ndltd.org/etd/rowan/oai:rdw.rowan.edu:etd-3549","repository":{"repo_id":"rowan","name":"Rowan University","base_url":"https://rdw.rowan.edu/do/oai/"},"display":{"title":"A study of albendazole and artemisinin drugs under electrochemical oxidation","abstract":"This work is aimed to investigate the metabolic behavior of albendazole and artemisinin. The electrochemical oxidation and reduction of these drugs were performed on electrode materials to mimic their metabolism in vivo using cyclic voltammetry and bulk electrolysis analysis. The oxidation of albendazole on gold electrode surface yielded albendazole sulfoxide and albendazole sulfone which are the main metabolites of this drug in vivo. Reduction of artemisinin on glassy carbon (GC) electrode surface yielded dihydroartemisinin and deoxy artemisinin. The formation of these products was monitored using liquid chromatography and mass spectrometry techniques. The redox processes for both drugs were shown to be irreversible and diffusion controlled. Bioactivation of artemisinin by hemoglobin was detected using a GC/carbon nanofibers (CNFs)/Hb biosensor. The catalytic effect of hemoglobin lowered the reduction potential of artemisinin by 475 mV. The apparent Michaelis-Menten constant (Km) was 0.093 mM which shows excellent biological activity of the CNFs bound hemoglobin. Additionally, the biosensor showed a linear relationship with increasing artemisinin concentration. Therefore, it can be useful to determine concentration of this drug in solution and matrices such as biological fluids.","abstract_html":"This work is aimed to investigate the metabolic behavior of albendazole and artemisinin. The electrochemical oxidation and reduction of these drugs were performed on electrode materials to mimic their metabolism in vivo using cyclic voltammetry and bulk electrolysis analysis. The oxidation of albendazole on gold electrode surface yielded albendazole sulfoxide and albendazole sulfone which are the main metabolites of this drug in vivo. Reduction of artemisinin on glassy carbon (GC) electrode surface yielded dihydroartemisinin and deoxy artemisinin. The formation of these products was monitored using liquid chromatography and mass spectrometry techniques. The redox processes for both drugs were shown to be irreversible and diffusion controlled. Bioactivation of artemisinin by hemoglobin was detected using a GC/carbon nanofibers (CNFs)/Hb biosensor. The catalytic effect of hemoglobin lowered the reduction potential of artemisinin by 475 mV. The apparent Michaelis-Menten constant (Km) was 0.093 mM which shows excellent biological activity of the CNFs bound hemoglobin. Additionally, the biosensor showed a linear relationship with increasing artemisinin concentration. Therefore, it can be useful to determine concentration of this drug in solution and matrices such as biological fluids.","abstract_has_math":false,"creators":["Mazzochette, Zahilis A."],"institution":null,"degree_name":"MS Pharmaceutical Sciences","degree_level":"Thesis","degree_discipline":"Chemistry and Biochemistry","degree_department":null,"school":null,"contributors":["Mugweru, Amos","Jonnalagadda, Subash","Vaden, Timothy"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":null,"date_issued":"","date_published":null,"updated_at":"2026-11-19T08:58:51Z","subjects":["Albendazole","Artemisinin","Cyclic voltammetry","Electrochemistry","Drugs--Analysis","Medicinal and Pharmaceutical Chemistry","Pharmacy and Pharmaceutical Sciences"],"languages":[],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":"https://rdw.rowan.edu/etd/2547","outbound_label":"Repository record","outbound_source":"dc:identifier","record_url":"https://rdw.rowan.edu/etd/2547","record_label":"Repository record","record_kind":"record","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://rdw.rowan.edu/do/oai/?verb=GetRecord&metadataPrefix=oai_etdms&identifier=oai%3Ardw.rowan.edu%3Aetd-3549","prefix":"oai_etdms"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Mugweru, Amos","Jonnalagadda, Subash","Vaden, Timothy"]},{"key":"dc:creator","label":"Author","values":["Mazzochette, Zahilis A."]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.available","label":"Dc Date Available","values":["2018-04-30T07:00:00Z"]},{"key":"dc:date.created","label":"Dc Date Created","values":["2018-04-26T07:00:00Z"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Chemistry and Biochemistry"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Thesis"]},{"key":"thesis:degree_name","label":"Degree Name","values":["MS Pharmaceutical Sciences"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Albendazole","Artemisinin","Cyclic voltammetry","Electrochemistry","Drugs--Analysis","Medicinal and Pharmaceutical Chemistry","Pharmacy and Pharmaceutical Sciences"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://rdw.rowan.edu/etd/2547"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["This work is aimed to investigate the metabolic behavior of albendazole and artemisinin. The electrochemical oxidation and reduction of these drugs were performed on electrode materials to mimic their metabolism in vivo using cyclic voltammetry and bulk electrolysis analysis. The oxidation of albendazole on gold electrode surface yielded albendazole sulfoxide and albendazole sulfone which are the main metabolites of this drug in vivo. Reduction of artemisinin on glassy carbon (GC) electrode surface yielded dihydroartemisinin and deoxy artemisinin. The formation of these products was monitored using liquid chromatography and mass spectrometry techniques. The redox processes for both drugs were shown to be irreversible and diffusion controlled. Bioactivation of artemisinin by hemoglobin was detected using a GC/carbon nanofibers (CNFs)/Hb biosensor. The catalytic effect of hemoglobin lowered the reduction potential of artemisinin by 475 mV. The apparent Michaelis-Menten constant (Km) was 0.093 mM which shows excellent biological activity of the CNFs bound hemoglobin. Additionally, the biosensor showed a linear relationship with increasing artemisinin concentration. Therefore, it can be useful to determine concentration of this drug in solution and matrices such as biological fluids."]},{"key":"dc:title","label":"Title","values":["A study of albendazole and artemisinin drugs under electrochemical oxidation"]}]}],"canonical_facts":{"dc:contributor":["Mugweru, Amos","Jonnalagadda, Subash","Vaden, Timothy"],"dc:creator":["Mazzochette, Zahilis A."],"dc:date.available":["2018-04-30T07:00:00Z"],"dc:date.created":["2018-04-26T07:00:00Z"],"dc:description.abstract":["This work is aimed to investigate the metabolic behavior of albendazole and artemisinin. The electrochemical oxidation and reduction of these drugs were performed on electrode materials to mimic their metabolism in vivo using cyclic voltammetry and bulk electrolysis analysis. The oxidation of albendazole on gold electrode surface yielded albendazole sulfoxide and albendazole sulfone which are the main metabolites of this drug in vivo. Reduction of artemisinin on glassy carbon (GC) electrode surface yielded dihydroartemisinin and deoxy artemisinin. The formation of these products was monitored using liquid chromatography and mass spectrometry techniques. The redox processes for both drugs were shown to be irreversible and diffusion controlled. Bioactivation of artemisinin by hemoglobin was detected using a GC/carbon nanofibers (CNFs)/Hb biosensor. The catalytic effect of hemoglobin lowered the reduction potential of artemisinin by 475 mV. The apparent Michaelis-Menten constant (Km) was 0.093 mM which shows excellent biological activity of the CNFs bound hemoglobin. Additionally, the biosensor showed a linear relationship with increasing artemisinin concentration. Therefore, it can be useful to determine concentration of this drug in solution and matrices such as biological fluids."],"dc:identifier":["https://rdw.rowan.edu/etd/2547"],"dc:subject":["Albendazole","Artemisinin","Cyclic voltammetry","Electrochemistry","Drugs--Analysis","Medicinal and Pharmaceutical Chemistry","Pharmacy and Pharmaceutical Sciences"],"dc:title":["A study of albendazole and artemisinin drugs under electrochemical oxidation"],"thesis:degree_discipline":["Chemistry and Biochemistry"],"thesis:degree_level":["Thesis"],"thesis:degree_name":["MS Pharmaceutical Sciences"]},"updated_at":"2026-11-19T08:58:51Z"}